Skip to main content
. 2018 Feb 7;34(2):167–175. doi: 10.1002/joa3.12034

Table 1.

Baseline characteristics

Characteristic All patients (N = 11 308) Patients from clinics with beds ≤19 (N = 5396) Patients from hospitals with beds ≥20 (N = 5912)
Age‐y 73.1 ± 9.9 73.2 ± 9.8 73.1 ± 9.9
<75 y‐no. (%) 5804 (51.3) 2764 (51.2) 3040 (51.4)
≥75 y‐no. (%) 5504 (48.7) 2632 (48.8) 2872 (48.6)
Female sex‐no. (%) 4306 (38.1) 2125 (39.4) 2181 (36.9)
Height‐cm 160.2 ± 9.9 160.0 ± 10.1 160.3 ± 9.7
Body weight‐kg 60.9 ± 12.6 61.2 ± 12.6 60.7 ± 12.7
Body weight‐no. (%)
≤50 kg 2209 (19.5) 1011 (18.7) 1198 (20.3)
>50 kg 8081 (71.5) 3887 (72.0) 4194 (70.9)
Unknown 1018 (9.0) 498 (9.2) 520 (8.8)
BMI‐kg/m2 23.7 ± 3.8 23.9 ± 3.6 23.6 ± 3.9
BMI‐no. (%)
<18.5 615 (5.4) 228 (4.2) 387 (6.6)
18.5 to <25 5348 (47.3) 2495 (46.2) 2853 (48.3)
25 to <30 2493 (22.0) 1230 (22.8) 1263 (21.4)
≥30 483 (4.3) 232 (4.3) 251 (4.3)
Unknown 2369 (20.9) 1211 (22.4) 1158 (19.6)
Creatinine clearance‐mL/min 67.7 ± 28.9 68.5 ± 31.2 67.0 ± 26.5
Creatinine clearance‐no. (%)
<15 mL/min 3 (0.03) 2 (0.04) 1 (0.02)
15 to < 30 mL/min 312 (2.8) 131 (2.4) 181 (3.1)
30 to < 50 mL/min 2382 (21.1) 1099 (20.4) 1283 (21.7)
50 to < 80 mL/min 4792 (42.4) 2278 (42.2) 2514 (42.5)
≥80 mL/min 2895 (25.6) 1428 (26.5) 1467 (24.8)
Unknown 924 (8.2) 458 (8.5) 466 (7.9)
CHADS2 score 2.2 ± 1.3 2.1 ± 1.3 2.3 ± 1.3
CHADS2 score‐no. (%)
0 985 (8.7) 498 (9.2) 487 (8.2)
1 2802 (24.8) 1439 (26.7) 1363 (23.1)
2 3400 (30.1) 1701 (31.5) 1699 (28.7)
3 2206 (19.5) 951 (17.6) 1255 (21.2)
4 1294 (11.4) 532 (9.9) 762 (12.9)
5 514 (4.5) 223 (4.1) 291 (4.9)
6 107 (0.9) 52 (1.0) 55 (0.9)
Baseline comorbidities‐no. (%)
Hypertension 8405 (74.3) 4094 (75.9) 4311 (72.9)
Diabetes mellitus 2523 (22.3) 1182 (21.9) 1341 (22.7)
Previous stroke or transient ischemic attack 2675 (23.7) 995 (18.4) 1680 (28.4)
Congestive heart failure 2826 (25.0) 1351 (25.0) 1475 (24.9)
Switch from other anticoagulants‐no. (%)
No 5291 (46.8) 2380 (44.1) 2911 (49.2)
Yes 6017 (53.2) 3016 (55.9) 3001 (50.8)
Warfarin 3960 (35.0) 1909 (35.4) 2051 (34.7)
Dabigatran 1688 (14.9) 915 (17.0) 773 (13.1)
Other 369 (3.3) 192 (3.6) 177 (3.0)

Plus‐minus values are means ±SD.